Coinbase is seeking a green light from the U.S. Securities and Exchange Commission to offer "tokenized equities" to its customers, the crypto exchange's chief legal officer told Reuters.

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device ...

TL;DR Key Takeaways : OpenAI’s new Input/Output (IO) device transforms human-AI interaction by allowing natural, conversational communication, making AI more intuitive and user-friendly.

NEWTOWN, Pa., June 16, 2025 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic ...

Helius Medical Technologies, Inc. Announces Claim Authorization By Cignahealth, For Its Portable Neuromodulation Stimulator (Pons®) Device Date 2025-06-16 07:16:13 ...

Elon Musk’s Neuralink Corp. used a brain implant to enable a monkey to see something that wasn’t physically there, according to an engineer, as it moves toward its goal of helping blind people ...

There is a nearly five-year gap between when a new medical device receives FDA approval and is subsequently covered by Medicare.

- CignaHealth becomes fifth major payer to authorize claim for PoNS Device at out-of-network adjusted negotiated list price of $19,161- -This follows another recent authorization by Anthem ...

Coinbase announced in April that it would be expanding its operations in Charlotte. The move was part of the platform’s overall growth strategy to employ over 1,000 people in the U.S. this year.

CignaHealth becomes the fifth major payer to authorize claims for payment for the PoNS Device following the recent authorization by Anthem MultiPlan. "With approvals now secured from five major ...

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device Provided by GlobeNewswire Jun 16, 2025, 11:00:00 AM ...

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced that CignaHealth has authorized claims for payment of the company’s Portable Neuromodulation Stimulator (PoNS) Device.